Working with Data – From Reactive to Strategic

Friedemann Lutz
Friedemann Lutz
Data is one of the key resources of any organization. The good news is, there is lots of data available, inside and outside your organization.

Latest posts

Working with Data – From Reactive to Strategic
Data is one of the key resources of any organization. The good news is, there is lots of data available, inside and outside your organization.
Working with Data - From Reactive to Strategic
19 minutes
10 November, 2021
Five recommendations for successful project portfolio management in the digital world
We all know that the pace of change increases continuously, but faced with the COVID-19 pandemic we learned that there are forces making us change even faster and in a global perspective. Process redesign...
Five recommendations for successful project portfolio management in the digital world
7 minutes
6 July, 2021
Survey Report: “Sustainability is a driver of innovation in leading companies”
Together with Bird & Bird's Retail & Consumer team, OXYGY surveyed clients on the impact of sustainability on business priorities, innovation and leadership. We talked to David Rosenberg (Director Sustainability...
Survey Report: “Sustainability is a driver of innovation in leading companies”
3 minutes
29 June, 2021
Bird & Bird & OXYGY’s Trade Secrets Solution – Phase 3
In our experience speaking with GCs, CIO, CTO, CPO & CCOs (Chief Innovation, Technology, People & Compliance Officers) about Trade Secrets, they often mention not being able to convince their CEOs of the...
Bird & Bird & OXYGY’s Trade Secrets Solution - Phase 3
4 minutes
23 June, 2021
OXYGY announces the appointment of Bird & Bird partner Maria Carlsson as a member of its Board
International law firm Bird & Bird’s management consultancy arm, OXYGY today announces the appointment of Maria Carlsson as member of its Board.
2 minutes
21 June, 2021
Podcast: An Integrated Development and Commercialization Process for New Medicines
John Glasspool, CEO and President of Anthos Therapeutics met with Steve Crom to discuss the challenges of giving patients access to new medicines.
Podcast: An Integrated Development and Commercialization Process for New Medicines
1 minute
15 June, 2021
Load more

Stay in touch